Morningside Venture Investments Ltd

Insider Reports History

Location
Newton Centre, MA
Signature
/s/ Frances Anne Elizabeth Richard, Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Morningside Venture Investments Ltd:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. 10%+ Owner Common Stock 12,806,342 $815,635,922 $63.69 18 Nov 2021 Direct
Amylyx Pharmaceuticals, Inc. 10%+ Owner Common Stock 4,997,302 $81,596,447 $16.33 15 Aug 2023 Direct
Kezar Life Sciences, Inc. 10%+ Owner Common Stock 1,947,993 $1,753,194 $0.9000 15 Aug 2023 Direct
GreenLight Biosciences Holdings, PBC 10%+ Owner Common Stock 0 $0.3000 24 Jul 2023 Direct

Insider Reports Filed by Morningside Venture Investments Ltd

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KZR Kezar Life Sciences, Inc. 15 Aug 2023 1 $0 4 10%+ Owner 17 Aug 2023, 19:08
AMLX Amylyx Pharmaceuticals, Inc. 15 Aug 2023 1 $0 4 10%+ Owner 17 Aug 2023, 17:34
/report/000095017023034397-morningside-venture-investments-ltd-2023-07-24 GreenLight Biosciences Holdings, PBC 24 Jul 2023 1 $0 4 10%+ Owner 25 Jul 2023, 16:01
AMLX Amylyx Pharmaceuticals, Inc. 29 Mar 2023 1 -$884,512 4 10%+ Owner 31 Mar 2023, 16:05
AMLX Amylyx Pharmaceuticals, Inc. 27 Mar 2023 3 -$4,896,561 4 10%+ Owner 29 Mar 2023, 16:05
AMLX Amylyx Pharmaceuticals, Inc. 21 Mar 2023 2 -$2,024,494 4 10%+ Owner 23 Mar 2023, 16:05
AMLX Amylyx Pharmaceuticals, Inc. 16 Mar 2023 1 -$296,921 4 10%+ Owner 17 Mar 2023, 16:05
AMLX Amylyx Pharmaceuticals, Inc. 14 Mar 2023 3 -$7,433,459 4 10%+ Owner 16 Mar 2023, 16:11
AMLX Amylyx Pharmaceuticals, Inc. 02 Mar 2023 1 -$1,687,500 4 10%+ Owner 06 Mar 2023, 08:10
AMLX Amylyx Pharmaceuticals, Inc. 24 Feb 2023 2 -$1,736,352 4 10%+ Owner 28 Feb 2023, 15:06
AMLX Amylyx Pharmaceuticals, Inc. 22 Feb 2023 4 -$3,578,103 4 10%+ Owner 24 Feb 2023, 15:13
KZR Kezar Life Sciences, Inc. 03 Feb 2023 2 -$453,970 4 10%+ Owner 07 Feb 2023, 15:11
KZR Kezar Life Sciences, Inc. 01 Feb 2023 2 -$637,500 4 10%+ Owner 03 Feb 2023, 15:32
KZR Kezar Life Sciences, Inc. 30 Jan 2023 2 -$419,700 4 10%+ Owner 01 Feb 2023, 15:07
KZR Kezar Life Sciences, Inc. 25 Jan 2023 1 -$342,500 4 10%+ Owner 27 Jan 2023, 15:17
KZR Kezar Life Sciences, Inc. 23 Jan 2023 2 -$1,103,200 4 10%+ Owner 25 Jan 2023, 17:17
KZR Kezar Life Sciences, Inc. 17 Jan 2023 1 -$41,514 4 10%+ Owner 19 Jan 2023, 15:12
KZR Kezar Life Sciences, Inc. 12 Jan 2023 2 -$47,943 4 10%+ Owner 17 Jan 2023, 15:28
KZR Kezar Life Sciences, Inc. 05 Jan 2023 2 -$105,439 4 10%+ Owner 09 Jan 2023, 15:08
KZR Kezar Life Sciences, Inc. 31 Dec 2022 1 $0 5 10%+ Owner 11 Jan 2023, 15:09
AMLX Amylyx Pharmaceuticals, Inc. 31 Dec 2022 4 $0 5 10%+ Owner 11 Jan 2023, 15:07
KZR Kezar Life Sciences, Inc. 29 Dec 2022 3 -$396,150 4 10%+ Owner 05 Jan 2023, 15:10
KZR Kezar Life Sciences, Inc. 03 Oct 2022 2 -$283,815 4 10%+ Owner 05 Oct 2022, 16:05
/report/000089924322028680-morningside-venture-investments-ltd-2022-08-11 GreenLight Biosciences Holdings, PBC 11 Aug 2022 1 +$11,999,998 4 10%+ Owner 15 Aug 2022, 18:48
/report/000089924322011438-morningside-venture-investments-ltd-2022-02-02 GreenLight Biosciences Holdings, PBC 02 Feb 2022 0 $0 3 10%+ Owner 17 Mar 2022, 17:33
/report/000089924322011429-morningside-venture-investments-ltd-2022-02-02-restatement GreenLight Biosciences Holdings, PBC 02 Feb 2022 4 -$10,000,000 4/A 10%+ Owner 17 Mar 2022, 17:11
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2022 6 +$5,000,002 4/A 10%+ Owner 17 Mar 2022, 17:14
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2022 0 $0 3/A 10%+ Owner 17 Mar 2022, 17:14
APLS Apellis Pharmaceuticals, Inc. 18 Nov 2021 1 +$10,000,000 4 10%+ Owner 18 Nov 2021, 15:16